| |
| |
|
| Insider
Information: |
Hegde Sharathchandra S |
| Relationship: |
SVP, Research |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
259,900 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,201,353 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
259,900 |
|
|
| Total
Value |
$2,201,353 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Theravance Biopharma, Inc. |
TBPH |
SVP, Research |
2019-08-20 |
259,900 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
SVP, ResearchOfficer |
• – – |
2016-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
72,165 |
|
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
177,165 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2016-05-20 |
4 |
D |
$20.55 |
$37,935 |
D/D |
(1,846) |
175,319 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2016-08-20 |
4 |
D |
$27.89 |
$51,485 |
D/D |
(1,846) |
173,473 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2016-11-20 |
4 |
D |
$31.96 |
$58,966 |
D/D |
(1,845) |
171,628 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
180,628 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2017-02-20 |
4 |
D |
$33.78 |
$342,462 |
D/D |
(10,138) |
170,490 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2017-05-20 |
4 |
D |
$36.83 |
$190,669 |
D/D |
(5,177) |
165,313 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2017-08-20 |
4 |
D |
$27.40 |
$141,822 |
D/D |
(5,176) |
160,137 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2017-11-20 |
4 |
D |
$28.58 |
$147,959 |
D/D |
(5,177) |
154,960 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
163,960 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2018-02-20 |
4 |
D |
$29.09 |
$126,512 |
D/D |
(4,349) |
159,611 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
193,361 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2018-05-20 |
4 |
D |
$24.31 |
$464,394 |
D/D |
(19,103) |
174,258 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2018-08-20 |
4 |
D |
$26.95 |
$140,086 |
D/D |
(5,198) |
169,060 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2018-11-20 |
4 |
D |
$24.79 |
$100,722 |
D/D |
(4,063) |
164,997 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,250 |
277,247 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2019-02-20 |
4 |
D |
$27.00 |
$101,790 |
D/D |
(3,770) |
273,477 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2019-03-04 |
4 |
S |
$25.06 |
$83,764 |
D/D |
(3,343) |
270,134 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2019-03-05 |
4 |
S |
$24.50 |
$139,405 |
D/D |
(5,690) |
264,444 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2019-05-20 |
4 |
D |
$19.84 |
$45,076 |
D/D |
(2,272) |
262,172 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research |
• – – |
2019-08-20 |
4 |
D |
$21.51 |
$48,871 |
D/D |
(2,272) |
259,900 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
